‘I’m a fitness coach. I tried a GLP-1 drug for three weeks’
A fitness coach shares their personal experience experimenting with GLP-1 weight-loss drugs like Ozempic. The author emphasizes that while these drugs are useful tools for metabolic health, they should be used under medical supervision rather than as a quick fix.
Why it matters
As GLP-1 drugs gain popularity for weight loss, understanding the balance between medical utility and potential misuse is critical for public health.
Last month, I injected myself with a GLP-1 drug and became my own lab rat for three weeks.
As a fitness coach with my weight well under control, I didn’t need this. And yet, I took it. Why?
I work with people to treat their metabolic disease — obesity, diabetes, fatty liver, PMOS, metabolic syndrome. GLP-1 medicines, including semaglutide (the drug in Ozempic) and tirzepatide (the drug in Mounjaro), are among the tools we use. My job is to guide users to a healthy lifestyle (the right kind of activity, better food, improved sleep), while my medical team monitors their health markers. Our goal is to get them off the drug, with their health intact.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in